Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib

NCT00348491 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

364

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: Lumiracoxib

Sponsor

Novartis Pharmaceuticals